. 2005 May 3;92(10):1881–1891. doi: 10.1038/sj.bjc.6602592

Table 1. Cell cycle analysis after treatment with imatinib.

Time (days)	Treatment	%G₀/G₁	%S	%G₂/M
4	Control	60.33±2.3	35.52±4.4	3.26±4.3
	15 μM IM	58.01±2.2	26.88±2.5*	15.1±1.1*
5	Control	60.28±4.9	28.7±3.9	9.5±1.6
	15 μM IM	68.35±3.0*	22.13±3.6*	11.95±1.8*

IM=imatinib mesylate.

P-value <0.05.